Anabolic androgen steroids (AAS) such as nanderlone decaneate (ND) are used in athletes to enhance their muscular performance, body weight, fighting and physical potency [
1,
2]. The long-term AAS use seems to modify body foundation, muscle physique and reduce fat mass in athletes [
3]. In addition, ND is used to treat anemia in patients on hemodialysis [
4-
6]. Assessment exposed that an extended management of AAS remains a series injures in different organs, particularly, in liver, and causes elevation of the liver enzymes [
7]. Lesna and Taylor showed that anabolic androgen steroids caused the hepatoxicity in mice with and without pretreatment with diethylnitrosamine enhanced [
8]. On the other hand, administration of ND causes the increase of the glutathione-s-transferases enzyme activity in mice [
9]. In patients who were treated with ND the serum levels of cholesterol and triglyceride were increased unlike the high-density lipoprotein concentration which was decreased compared with that on the control groups [
10,
11]. Kafrouni et al. pronounced that AAS are being sold as dietary supplements and are still the main cause of hepatotoxicity in the United States [
12]. Our serach gives evidence for wide ranging effects of AAS on the hypothalamic-pituitary-adrenal axis and adipose tissue [
13,
14]. Unlike the above report, some studies have shown that ND causes the liver regeneration enhances faster in rats after partial hepatectomy [
15] but Alberti-Flor et al. showed that the use of synthetic anabolic androgen causes focal nodular hyperplasia in rats [
16].